Abstract
Systemic rheumatological diseases are often accompanied by the development of central and peripheral nervous system pathology. Data providing evidence of the high incidence of peripheral nervous system lesions in systemic lupus erythematosus and systemic scleroderma are presented. These diseases in particular are characterized by polyneuropathies and tunnel syndromes. Our own observations, along with published data, revealed the following major pathogenetic mechanisms of peripheral nervous system lesions in diffuse connective tissue diseases-ischemic, immunological, and metabolic. Consideration of these mechanisms will lead to pathogenetically based treatment and improved therapeutic outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. S. Gitkina, G. S. Severin, and O. P. Shatyko, On the Question of Lesions to the Peripheral Nervous System in Patients with Systemic Lupus Erythematosus: A Handbook, [in Russian], Minsk (1987), Vol. 10, pp. 64–69.
N. G. Guseva, Systemic Scleroderma and Pseudosclerodermic Syndromes [in Russian], Meditsina, Moscow (1993).
R. P. Lisak and A. I. Levinson, “Neuropathy in connective tissue diseases,” in: Peripheral Nerve Disorders [Translated from English], A. K. Asbery and R. U. Gilliatt (eds.), Meditsina, Moscow (1987), pp. 195–228.
Z. S. Manelis, N. N. Spirin, R. V. Kurapin, and A. M. Bulanov, Neurological Lesions in Systemic Lupus Erythematosus. Clinical Aspects, Treatment, and Rehabilitation of Patients with Rheumatic Diseases: A Handbook [in Russian], Yaroslavl’ (1989), pp. 89–91.
Peripheral Neuropathies: WHO Study Group Report, Geneva (1982).
N. V. Pizova, Vascular Lesions of the Brain in Some Rheumatological Diseases [in Russian], Author’s abstract of thesis for doctorate in medical sciences, Moscow (2004).
N. N. Spirin, The Neuromotor Apparatus, the Autonomic Nervous System, and Non-Specific Brain Structures in Systemic Vasculitides [in Russian], Author’s abstract of thesis for doctorate in medical sciences, Yaroslavl’ (1994).
I. Campello, J. Velilla, C. Almarcegui, and I. Perez Lopez-Fraile, “Trigeminal neuropathy in progressive systemic sclerosis,” Rev. Neurol., 25, 137 (1997).
D. A. Farrell and T. A. Medsger, “Trigeminal neuropathy in progressive systemic sclerosis,” Amer. J. Med., 73, No. 1, 57–62 (1982).
A. Hietaharju, S. Jaaskelainen, H. Kalimo, and M. Hietarinta, “Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma),” Muscle Nerve, 16, No. 11, 1204–1212 (1993).
C. Huynh, S. L. Ho, K. Y. Fong, et al., “Peripheral neuropathy in systemic lupus erythematosus, ” J. Clin. Neurophysiol., 16, No. 2, 164–168 (1999).
A. T. Masi, G. P. Rodnan, T. A. Medsger, Jr., et al., “Preliminary criteria for the classification of systemic sclerosis (scleroderma),” Arthr. Rheumatol., 23, No. 5, 581–590 (1980).
P. A. McCombe, R. Wilson, and R. L. Prentice, “Results of testing for anti-GM1 antibodies,” J. Clin. Neurosci., 7, No. 3, 209–212 (2000).
M. Mondelli, C. Romano, R. Della Porta, and A. Rossi, “Electrophysiological evidence of ‘nerve entrapment syndromes’ and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma),” J. Neurol., 242, 185–194 (1995).
L. Mouthon, C. Halimi, G. P. Muller, et al., “Systemic scleroderma associated with bilateral ulnar nerve entrapment at the elbow,” Rheumatology (Oxford), 39, No. 6, 682–683 (2000).
R. K. Olney, “Neuropathies associated with connective tissue disease,” Semin. Neurol., 18, No. 1, 63–72 (1998).
R. Omdal, S. I. Mellgren, and G. Husby, “Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus,” Scand. J. Rheum., 17, No. 2, 113–117 (1988).
R. Rosenbaum, “Neuromuscular complications of connective tissue diseases,” Muscle Nerve, 24, No. 2, 154–169 (2001).
M. Soubrier, M. Vidailhet, P. Clavelou, et al., “Trigeminal neuropathy and connective tissue diseases,” Ann. Med. Int., 144, No. 6, 379–382 (1993).
R. H. Straub, M. Zeuner, G. Lock, et al., “Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis,” J. Rheumatol., 23, No. 1, 87–92 (1996).
E. M. Tan, A. S. Cohen, J. F. Fries, et al., “The 1982 revised criteria for the classification of systemic lupus erythematosus,” Arthr. Rheumatol., 25, No. 11, 1271–1277 (1982).
E. U. Uetz von Allmen, M. Stuzenegger, R. Rieben, et al., “Antiganglioside GMI antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls,” Eur. Neurol., 39, No. 2, 103–110 (1998).
Author information
Authors and Affiliations
Additional information
__________
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 105, No. 12, pp. 4–8, December, 2005.
Rights and permissions
About this article
Cite this article
Spirin, N.N., Bulanova, V.A., Pizova, N.V. et al. Peripheral nervous system lesion syndromes and the mechanisms of their formation in connective tissue diseases. Neurosci Behav Physiol 37, 1–6 (2007). https://doi.org/10.1007/s11055-007-0141-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11055-007-0141-1